Latest News

Outsourcing in Clinical Trials UK & Ireland | June 14-15

24/05/2022

Are you attending the Outsourcing in Clinical Trials UK & Ireland meeting in London? This event will bring together attendees from both large and small established pharma alongside biopharmaceutical companies and provide opportunities to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region. Simbec-Orion supports full service, […]

Read More

BIO International | June 13-16 | Meet Us in San Diego!

24/05/2022

We are excited to share that we will be attending BIO International in San Diego and are looking forward to re-connecting with our scientific colleagues in person. Our team would love to learn more about your clinical development goals and share how Simbec-Orion can support your team with flexible, thoughtful study design and deep scientific […]

Read More

American Society of Clinical Oncology Annual Meeting 2022

23/05/2022

The 2022 ASCO Annual Meeting Program will offer presentations on the latest research in cancer care. This year’s program will feature over 200 sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through Innovation. Our colleagues, Dr Moonmoon Kazi and Maria Frane are excited to be attending #ASCO2022 in Chicago next month and looking forward to […]

Read More

Simbec-Orion Modernizing Quality and Compliance with Veeva Vault Quality Suite

18/05/2022

Implementing Veeva Vault Quality Suite applications will help Simbec-Orion increase efficiency through digital execution, as well as strengthen QA processes, driving quality and oversight across our operations. Read the press release here. You might also be interested in reading our news about Alison Hughes, Head of Business Enablement at Simbec-Orion, being recognised as a Veeva […]

Read More

Meet the Team | Tracy Thomas

13/05/2022

We are excited to launch a new blog series where we talk to members of our more than 400- strong team about why they enjoy their role at Simbec-Orion. We previously spoke with Dr Maria Kozlak on a day in the life of a CRA. This month we are speaking with Tracy Thomas, Head of […]

Read More

Lupuzor™ Phase III Trials: Partnering With Immupharma

03/02/2022

Lupuzor™ is an in-development treatment for Lupus, a chronic inflammatory disease thought to affect around 5 million people worldwide. Having recently undergone FDA approval, Lupuzor™ is commencing into phase 3 clinical trials. Simbec-Orion are proud to have been selected by ImmuPharma as a partner to conduct the international phase 3 trial of Lupuzor™ involving pharmacokinetic […]

Read More

Using biomarker clinical trial design to drive rare respiratory disease results

03/02/2022

Simbec-Orion recently helped a biotech sponsor demonstrate the safety and tolerability of a new trial treatment for idiopathic pulmonary fibrosis (IPF). Devising an effective umbrella trial design adapted to the needs of IPF patients, we were able to deliver final CSR results ahead of time. Our researchers devised and conducted the umbrella study design testing […]

Read More

Got a question?
Get in Touch or Submit an RFI/RFP

Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email enrolmentservices@simbecorion.com

Follow us on Social Media

Name(Required)
Opt In Emails